EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

Health Effects of High-Concentration Cannabis Products: Scoping Review and Evidence Map

Lisa Bero, Rosa Lawrence, Jean-Pierre Oberste, Tianjing Li, Louis Leslie, Thanitsara Rittiphairoj, Christi Piper, George Sam Wang, Ashley Brooks-Russell, Tsz Wing Yim, Gregory Tung, Jonathan M Samet

American Journal of Public Health · 2023-12 · 113 (12) · 1332-1342

DOI: 10.2105/ajph.2023.307414 ↗

Kurz gefasst

Scoping Review in der Zeitschrift American Journal of Public Health, 2023-12. Verfasst von Lisa Bero und 11 weiteren Autor:innen. Beteiligte Einrichtung: Lisa Bero and Rosa Lawrence are with the Department of General Internal Medicine, Center for Bioethics and Humanities, University of Colorado, Anschu…. Hauptthemen laut MEDLINE: Cannabis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The concentration of pharmacologically active tetrahydrocannabinol (THC) in cannabis products has been increasing over the past decade. Concerns about potential harmful health effects of using these increasingly higher-concentration products have led some states to consider regulation of cannabis product THC concentration. We conducted a scoping review of health effects of high-concentration cannabis products to inform policy on whether the THC concentrations of cannabis product should be regulated or limited.

Objectives

We conducted a scoping review to (1) identify and describe human studies that explore the relationship of high-concentration cannabis products with any health outcomes in the literature and (2) create an interactive evidence map of the included studies to facilitate further analyses. Search Methods. An experienced medical information specialist designed a comprehensive search strategy of 7 electronic databases. Selection Criteria. We included human studies of any epidemiological design with no restrictions by age, sex, health status, country, or outcome measured that reported THC concentration or included a known high-concentration cannabis product. Data Collection and Analysis. We imported search results into Distiller SR, and trained coders conducted artificial intelligence‒assisted screening. We developed, piloted, and revised data abstraction forms. One person performed data abstraction, and a senior reviewer verified a subset. We provide a tabular description of study characteristics, including exposures and outcomes measured, for each included study. We interrogated the evidence map published in Tableau to answer specific questions and provide the results as text and visual displays. Main Results. We included 452 studies in the scoping review and evidence map. There was incomplete reporting of exposure characteristics including THC concentration, duration and frequency of use, and products used. The evidence map shows considerable heterogeneity among studies in exposures, outcomes, and populations studied. A limited number of reports provided data that would facilitate further quantitative synthesis of the results across studies.

Conclusions

This scoping review and evidence map support strong conclusions concerning the utility of the literature for characterizing risks and benefits of the current cannabis marketplace and the research approaches followed in the studies identified. Relevance of the studies to today’s products is limited. Public Health Implications. High-quality evidence to address the policy question of whether the THC concentration of cannabis products should be regulated is scarce. The publicly available interactive evidence map is a timely resource for other entities concerned with burgeoning access to high-concentration cannabis. (Am J Public Health. 2023;113(12):1332–1342. https://doi.org/10.2105/AJPH.2023.307414 )

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisHumansArtificial IntelligenceAnalgesicsPublic Health

Substanzen

Analgesics

Autor:innen und Institutionen

  • Lisa Bero and Rosa Lawrence are with the Department of General Internal Medicine, Center for Bioethics and Humanities, University of Colorado, Anschutz Medical Campus, Aurora. Jean-Pierre Oberste, Tianjing Li, Louis Les…

Zitieren

APA

Bero, L., Lawrence, R., Oberste, J. P., Li, T., Leslie, L., Rittiphairoj, T., Piper, C., Wang, G. S., Brooks-Russell, A., Yim, T. W., Tung, G., & Samet, J. M. (2023). Health Effects of High-Concentration Cannabis Products: Scoping Review and Evidence Map. American Journal of Public Health, 113(12), 1332-1342. https://doi.org/10.2105/ajph.2023.307414

Vancouver

Bero L, Lawrence R, Oberste JP, Li T, Leslie L, Rittiphairoj T, et al. Health Effects of High-Concentration Cannabis Products: Scoping Review and Evidence Map. American Journal of Public Health. 2023;113(12):1332-1342. doi:10.2105/ajph.2023.307414

BibTeX
@article{Bero2023,
  author = {Bero, Lisa and Lawrence, Rosa and Oberste, Jean-Pierre and Li, Tianjing and Leslie, Louis and Rittiphairoj, Thanitsara and Piper, Christi and Wang, George Sam and Brooks-Russell, Ashley and Yim, Tsz Wing and Tung, Gregory and Samet, Jonathan M},
  title = {Health Effects of High-Concentration Cannabis Products: Scoping Review and Evidence Map},
  journal = {American Journal of Public Health},
  year = {2023},
  volume = {113},
  number = {12},
  pages = {1332--1342},
  doi = {10.2105/ajph.2023.307414}
}
Kostenlos starten →